- recruitingPHASE3
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
This study looks at new treatments for advanced lung cancer that has stopped responding to previous therapies. It compares a new drug combination with standard chemotherapy to see if it's more effective and safe for patients who have already tried other treatments.
United States · Canada · United Kingdom - active not recruitingPHASE2
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
This study is looking at a new drug called adagrasib for people with a specific type of advanced lung cancer. It focuses on patients who are older (70+) or have poorer health, to see how well the drug works in shrinking their cancer.
Belgium · France · Ireland - not yet recruitingNA
Exercise in Patients With Advanced Non-small Cell Lung Cancer
This study looks at how exercise, like walking or strength training, might help people in the UK with advanced lung cancer. It aims to see if exercise can improve tiredness, strength, and overall well-being alongside their usual cancer treatment.
Germany